Genetic polymorphisms of XRCC1 and leukemia risk: A meta-analysis of 19 case-control studies

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Zhang, Haijun ^a   Liu, Hang ^b   Jiang, Gaofeng ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b School of Social Work ^*  (United States)

^c WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ARGININE; CYTOSINE; GLUTAMINE; GUANINE; HISTIDINE; THYMINE; TRYPTOPHAN; XRCC1 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CAUCASIAN; CODOMINANCE; DOMINANT INHERITANCE; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LEUKEMIA; RECESSIVE INHERITANCE; RISK ASSESSMENT; RISK FACTOR;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA; POLYMORPHISM, GENETIC;

EID: 84896698743     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080687     Document Type: Article

References (42)

1. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/. Based on November 2012 SEER data submission, posted to the SEER web site, 2013.
2. Berwick M, Vineis P (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92: 874-897. (Pubitemid 30429188)
3. Caldecott KW, Aoufouchi S, Johnson P, Shall S (1996) XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res 24: 4387-4394. (Pubitemid 26388624)
4. Dianov GL, Prasad R, Wilson SH, Bohr VA (1999) Role of DNA polymerase β in the excision step of long patch mammalian base excision repair. J Biol Chem 274: 13741-13743.
5. Thompson LH, West MG (2000) XRCC1 keeps DNA from getting stranded. Mutat Res 459: 1-18. (Pubitemid 30085463)
6. Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG (2012) Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract 18: 12-18.
7. Zhang H, Li W, Franklin MJ, Dudek AZ (2011) Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis. Anticancer Res 31: 3945-3952.
8. Zhang H, Liu H, Knauss JL (2013) Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis. Tumor Biol 34: 3003-3013.
9. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
10. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
11. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
12. Duval S, Tweedie R (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463. (Pubitemid 30422636)
13. R Development Core Team (2010) R: A language and environment for statistical computing.
14. Celkan T, Guven M, Batar B, Alhaj S (2008) The difference between pre-B cell acute lymphoblastic leukemia and Burkitt lymphoma in relation to DNA damage repair gene polymorphisms in childhood. Leuk Lymphoma 49: 1638-1640.
15. Annamaneni S, Gorre M, Kagita S, Addepalli K, Digumarti RR, et al. (2012) Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India. Hematology.
16. Abramenko I, Bilous N, Chumak A, Kostin A, Martina Z, et al. (2012) DNA repair polymorphisms in B-cell chronic lymphocytic leukemia in sufferers of Chernobyl Nuclear Power Plant accident. J Radiat Res 53: 497-503.
17. Batar B, Güven M, Bariş S, Celkan T, Yildiz I (2009) DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res 33: 759-763.
18. Canalle R, Silveira VS, Alberto Scrideli C, Queiroz RGP, Fernando Lopes L, et al. (2011) Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leukemia & Lymphoma 52: 1118-1126.
19. Deligezer U, Akisik EE, Dalay N (2007) Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia. Anticancer Res 27: 2453-2456. (Pubitemid 47228088)
20. Duman N, Aktan M, Ozturk S, Palanduz S, Cakiris A, et al. (2012) Investigation of Arg399Gln and Arg194Trp Polymorphisms of the XRCC1 (X-Ray Cross-Complementing Group 1) Gene and Its Correlation to Sister Chromatid Exchange Frequency in Patients with Chronic Lymphocytic Leukemia. Genetic Testing and Molecular Biomarkers 16: 287-291.
21. El-Din M, Raslan H, Abdel-Hamid S, Makhlouf M (2012) Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia. Comparative Clinical Pathology 21: 505-513.
22. Ganster C, Neesen J, Zehetmayer S, Jäger U, Esterbauer H, et al. (2009) DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 48: 760-767.
23. Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR (2005) DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett 217: 17-24. (Pubitemid 39642862)
24. Kim HN, Kim NY, Yu L, Huong Thi Thanh T, Kim YK, et al. (2012) Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status. Leukemia & Lymphoma 53: 681-687.
25. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, et al. (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27: 997-1007.
26. Meza-Espinoza JP, Peralta-Leal V, Gutierrez-Angulo M, Macias-Gomez N, Ayala-Madrigal ML, et al. (2009) XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia. Genet Mol Res 8: 1451-1458.
27. Özcan A, Pehlivan M, Tomatir AG, Karaca E, Özkinay C, et al. (2011) Polymorphisms of the DNA repair gene XPD (751) and XRCC1 (399) correlates with risk of hematological malignancies in Turkish population. African Journal of Biotechnology 10: 8860-8870.
28. Pakakasama S, Sirirat T, Kanchanachumpol S, Udomsubpayakul U, Mahasirimongkol S, et al. (2007) Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 48: 16-20. (Pubitemid 44871587)
29. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, et al. (2002) The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 100: 3761-3766. (Pubitemid 35303949)
30. Shi JY, Ren ZH, Jiao B, Xiao R, Yun HY, et al. (2011) Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. International Journal of Cancer 128: 233-238.
31. Stanczyk M, Sliwinski T, Cuchra M, Zubowska M, Bielecka-Kowalska A, et al. (2011) The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia. Mol Biol Rep 38: 445-451.
32. Tumer TB, Yilmaz D, Tanrikut C, Sahin G, Ulusoy G, et al. (2010) DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk Res 34: 1275-1281.
33. Sorour A, Ayad MW, Kassem H (2013) The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers 17: 195-201.
34. Hu Z, Ma H, Chen F, Wei Q, Shen H (2005) XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14: 1810-1818. (Pubitemid 40995099)
35. Zhang H, Pan Y, Zheng L, Choe C, Lindgren B, et al. (2011) FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res 71: 3257-3267.
36. Zhang HJ, Li WJ, Gu YY, Li SY, An GS, et al. (2010) p14ARF interacts with E2F factors to form p14ARF-E2F/partner-DNA complexes repressing E2F-dependent transcription. J Cell Biochem 109: 693-701.
37. Zhang HJ, Li WJ, Yang SY, Li SY, Ni JH, et al. (2009) 8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites. J Cell Biochem 106: 464-472.
38. Li WJ, Gu YY, Zhang HJ, Zhou J, Jia HT (2009) Induction of p14ARF by E2F1 contributes to 8-chloro-adenosine-induced apoptosis in human lung cancer H1299 cells. Chemotherapy 55: 335-343.
39. Ginsberg G, Angle K, Guyton K, Sonawane B (2011) Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutat Res 727: 1-15.
40. Dai L, Duan F, Wang P, Song C, Wang K, et al. (2012) XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep 39: 9535-9547.
41. Wang D, Qiu C, Zhang H, Wang J, Cui Q, et al. (2010) Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One 5: e13067.
42. Zhang H, Shykind B, Sun T (2012) Approaches to manipulating microRNAs in neurogenesis. Front Neurosci 6: 196.